Takizawa J, Suzuki R, Kuroda H, Utsunomiya A, Kagami Y, Joh T, Aizawa Y, Ueda R, Seto M
Laboratory of Chemotherapy, Aichi Cancer Center Research Institute, Nagoya.
Jpn J Cancer Res. 1998 Jul;89(7):712-8. doi: 10.1111/j.1349-7006.1998.tb03275.x.
The TCL1 gene was recently cloned as a candidate target within the 14q32.1 breakpoint cluster region observed in T-cell malignancies. We examined the TCL1 gene expression in 21 patients with adult T-cell leukemia (ATL) and 5 cell lines, because ATL is reported to have frequent chromosome 14 band q32 aberrations. However, 20 of the ATL patients and all 5 cell lines lacked any TCL1 expression on northern blot analysis, and TCL1 transcripts were only very faintly detected in the remaining one patient. Expansion of our analysis to include other types of hematopoietic malignancies revealed strong expression of the TCL1 gene in almost all tumor cells of B-cell lineage except myelomas. However, no TCL1 signals were encountered in cells of T-cell or myeloid lineages. In normal human tissues TCL1 was found to be expressed in the spleen, lymph nodes and B-lymphocytes of peripheral blood. These results indicate that TCL1 is not a major target gene for ATL, but that it may play a role in B-cell differentiation and proliferation.
TCL1基因最近被克隆出来,作为在T细胞恶性肿瘤中观察到的14q32.1断点簇区域内的一个候选靶点。我们检测了21例成人T细胞白血病(ATL)患者和5个细胞系中的TCL1基因表达,因为据报道ATL经常出现14号染色体q32带异常。然而,在Northern印迹分析中,20例ATL患者和所有5个细胞系均未检测到任何TCL1表达,仅在其余1例患者中非常微弱地检测到TCL1转录本。将我们的分析扩展到其他类型的造血恶性肿瘤后发现,除骨髓瘤外,TCL1基因在几乎所有B细胞系肿瘤细胞中均有强烈表达。然而,在T细胞或髓系细胞系中未检测到TCL1信号。在正常人体组织中,发现TCL1在脾脏、淋巴结和外周血B淋巴细胞中表达。这些结果表明,TCL1不是ATL的主要靶基因,但它可能在B细胞分化和增殖中起作用。